Demonstration of estrogen and vitamin D receptors in bone marrow-derived stromal cells: Up-regulation of the estrogen receptor by 1,25-dihydroxyvitamm-D3

Teresita Bellido, Giuseppe Girasole, Giovanni Passeri, Xiao Peng Yu, Hanna Mocharla, Robert L. Jilka, Angelo Notides, Stavros C. Manolagas

Research output: Contribution to journalArticle

91 Citations (Scopus)

Abstract

We have shown earlier that 17β-estradiol inhibits cytokine-induced interleukin-6 (IL-6) production by bone marrow-derived stromal cells as well as osteoblasts, two types of cells with a critical influence on orteoclast development, and that ovariectomy causes an IL-6-mediated up-regulation of osteoclastogenesis in mice. Prompted by this, we have searched here for the presence of estrogen receptors (ERs) in two murine bone marrow-derived stromal cell lines, +/+ LDA11 and MBA 13.2, and the osteoblast-like cell line MC3T3-E1. All three cell lines axhibited high affinity saturable binding for [125I] 17β-estradiol with a dissociation constant of approximately 10-10 M and concentration of binding sites of 260 ± 30, 170 ± 10, and 90 ± 10 sites per cell, respectively. In addition, we amplified complementary DNA from the stromal cell lines by polymerase chain reaction using oligonucleotide primers flanking the DNA binding domain of the murine uterine ER. The amplified product showed an identical nucleotide sequence to the DNA binding domain of the murine uterine receptor. Consistent with the functionality of the ER in stromal cells, and specifically its role in the regulation of IL-6 by 17β-estradiol, we found that the pure estrogen antagonist ICI 164,384 completely prevented the effect of 17β-estradiol on IL-6. All three cell lines also expressed receptors for 1,25-dihydroxyvitamin-D3 [1,25(OH)2D3] (dissociation constant, ∼10-10 M), with a concentration of binding sites of 490 ± 20, 920 ± 20, and 1110 ± 70 sites per cell, respectively. 1,25(OH)2D3 treatment of the stromal cells caused a 2-fold increase in the concentration of ERs and a decrease in cell proliferation. These data establish that bone marrow-derived stromal cells express functional estrogen as well as vitamin D receptors, which serve to mediate actions of their respective ligands on the biosynthetic activity of these cells and presumably the effects of these two steroid hormones on osteoclastogenesis.

Original languageEnglish
Pages (from-to)553-562
Number of pages10
JournalEndocrinology
Volume133
Issue number2
StatePublished - Aug 1993

Fingerprint

Calcitriol Receptors
Estrogen Receptor alpha
Mesenchymal Stromal Cells
Estrogens
Up-Regulation
Estrogen Receptors
Estradiol
Interleukin-6
Cell Line
Stromal Cells
Osteoblasts
Osteogenesis
Binding Sites
Estrogen Antagonists
DNA Primers
Interleukin-17
DNA
Ovariectomy
Complementary DNA
Steroids

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Bellido, T., Girasole, G., Passeri, G., Yu, X. P., Mocharla, H., Jilka, R. L., ... Manolagas, S. C. (1993). Demonstration of estrogen and vitamin D receptors in bone marrow-derived stromal cells: Up-regulation of the estrogen receptor by 1,25-dihydroxyvitamm-D3. Endocrinology, 133(2), 553-562.

Demonstration of estrogen and vitamin D receptors in bone marrow-derived stromal cells : Up-regulation of the estrogen receptor by 1,25-dihydroxyvitamm-D3. / Bellido, Teresita; Girasole, Giuseppe; Passeri, Giovanni; Yu, Xiao Peng; Mocharla, Hanna; Jilka, Robert L.; Notides, Angelo; Manolagas, Stavros C.

In: Endocrinology, Vol. 133, No. 2, 08.1993, p. 553-562.

Research output: Contribution to journalArticle

Bellido, T, Girasole, G, Passeri, G, Yu, XP, Mocharla, H, Jilka, RL, Notides, A & Manolagas, SC 1993, 'Demonstration of estrogen and vitamin D receptors in bone marrow-derived stromal cells: Up-regulation of the estrogen receptor by 1,25-dihydroxyvitamm-D3', Endocrinology, vol. 133, no. 2, pp. 553-562.
Bellido, Teresita ; Girasole, Giuseppe ; Passeri, Giovanni ; Yu, Xiao Peng ; Mocharla, Hanna ; Jilka, Robert L. ; Notides, Angelo ; Manolagas, Stavros C. / Demonstration of estrogen and vitamin D receptors in bone marrow-derived stromal cells : Up-regulation of the estrogen receptor by 1,25-dihydroxyvitamm-D3. In: Endocrinology. 1993 ; Vol. 133, No. 2. pp. 553-562.
@article{a56691e343f14a67a4b18f6f7c178b23,
title = "Demonstration of estrogen and vitamin D receptors in bone marrow-derived stromal cells: Up-regulation of the estrogen receptor by 1,25-dihydroxyvitamm-D3",
abstract = "We have shown earlier that 17β-estradiol inhibits cytokine-induced interleukin-6 (IL-6) production by bone marrow-derived stromal cells as well as osteoblasts, two types of cells with a critical influence on orteoclast development, and that ovariectomy causes an IL-6-mediated up-regulation of osteoclastogenesis in mice. Prompted by this, we have searched here for the presence of estrogen receptors (ERs) in two murine bone marrow-derived stromal cell lines, +/+ LDA11 and MBA 13.2, and the osteoblast-like cell line MC3T3-E1. All three cell lines axhibited high affinity saturable binding for [125I] 17β-estradiol with a dissociation constant of approximately 10-10 M and concentration of binding sites of 260 ± 30, 170 ± 10, and 90 ± 10 sites per cell, respectively. In addition, we amplified complementary DNA from the stromal cell lines by polymerase chain reaction using oligonucleotide primers flanking the DNA binding domain of the murine uterine ER. The amplified product showed an identical nucleotide sequence to the DNA binding domain of the murine uterine receptor. Consistent with the functionality of the ER in stromal cells, and specifically its role in the regulation of IL-6 by 17β-estradiol, we found that the pure estrogen antagonist ICI 164,384 completely prevented the effect of 17β-estradiol on IL-6. All three cell lines also expressed receptors for 1,25-dihydroxyvitamin-D3 [1,25(OH)2D3] (dissociation constant, ∼10-10 M), with a concentration of binding sites of 490 ± 20, 920 ± 20, and 1110 ± 70 sites per cell, respectively. 1,25(OH)2D3 treatment of the stromal cells caused a 2-fold increase in the concentration of ERs and a decrease in cell proliferation. These data establish that bone marrow-derived stromal cells express functional estrogen as well as vitamin D receptors, which serve to mediate actions of their respective ligands on the biosynthetic activity of these cells and presumably the effects of these two steroid hormones on osteoclastogenesis.",
author = "Teresita Bellido and Giuseppe Girasole and Giovanni Passeri and Yu, {Xiao Peng} and Hanna Mocharla and Jilka, {Robert L.} and Angelo Notides and Manolagas, {Stavros C.}",
year = "1993",
month = "8",
language = "English",
volume = "133",
pages = "553--562",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "2",

}

TY - JOUR

T1 - Demonstration of estrogen and vitamin D receptors in bone marrow-derived stromal cells

T2 - Up-regulation of the estrogen receptor by 1,25-dihydroxyvitamm-D3

AU - Bellido, Teresita

AU - Girasole, Giuseppe

AU - Passeri, Giovanni

AU - Yu, Xiao Peng

AU - Mocharla, Hanna

AU - Jilka, Robert L.

AU - Notides, Angelo

AU - Manolagas, Stavros C.

PY - 1993/8

Y1 - 1993/8

N2 - We have shown earlier that 17β-estradiol inhibits cytokine-induced interleukin-6 (IL-6) production by bone marrow-derived stromal cells as well as osteoblasts, two types of cells with a critical influence on orteoclast development, and that ovariectomy causes an IL-6-mediated up-regulation of osteoclastogenesis in mice. Prompted by this, we have searched here for the presence of estrogen receptors (ERs) in two murine bone marrow-derived stromal cell lines, +/+ LDA11 and MBA 13.2, and the osteoblast-like cell line MC3T3-E1. All three cell lines axhibited high affinity saturable binding for [125I] 17β-estradiol with a dissociation constant of approximately 10-10 M and concentration of binding sites of 260 ± 30, 170 ± 10, and 90 ± 10 sites per cell, respectively. In addition, we amplified complementary DNA from the stromal cell lines by polymerase chain reaction using oligonucleotide primers flanking the DNA binding domain of the murine uterine ER. The amplified product showed an identical nucleotide sequence to the DNA binding domain of the murine uterine receptor. Consistent with the functionality of the ER in stromal cells, and specifically its role in the regulation of IL-6 by 17β-estradiol, we found that the pure estrogen antagonist ICI 164,384 completely prevented the effect of 17β-estradiol on IL-6. All three cell lines also expressed receptors for 1,25-dihydroxyvitamin-D3 [1,25(OH)2D3] (dissociation constant, ∼10-10 M), with a concentration of binding sites of 490 ± 20, 920 ± 20, and 1110 ± 70 sites per cell, respectively. 1,25(OH)2D3 treatment of the stromal cells caused a 2-fold increase in the concentration of ERs and a decrease in cell proliferation. These data establish that bone marrow-derived stromal cells express functional estrogen as well as vitamin D receptors, which serve to mediate actions of their respective ligands on the biosynthetic activity of these cells and presumably the effects of these two steroid hormones on osteoclastogenesis.

AB - We have shown earlier that 17β-estradiol inhibits cytokine-induced interleukin-6 (IL-6) production by bone marrow-derived stromal cells as well as osteoblasts, two types of cells with a critical influence on orteoclast development, and that ovariectomy causes an IL-6-mediated up-regulation of osteoclastogenesis in mice. Prompted by this, we have searched here for the presence of estrogen receptors (ERs) in two murine bone marrow-derived stromal cell lines, +/+ LDA11 and MBA 13.2, and the osteoblast-like cell line MC3T3-E1. All three cell lines axhibited high affinity saturable binding for [125I] 17β-estradiol with a dissociation constant of approximately 10-10 M and concentration of binding sites of 260 ± 30, 170 ± 10, and 90 ± 10 sites per cell, respectively. In addition, we amplified complementary DNA from the stromal cell lines by polymerase chain reaction using oligonucleotide primers flanking the DNA binding domain of the murine uterine ER. The amplified product showed an identical nucleotide sequence to the DNA binding domain of the murine uterine receptor. Consistent with the functionality of the ER in stromal cells, and specifically its role in the regulation of IL-6 by 17β-estradiol, we found that the pure estrogen antagonist ICI 164,384 completely prevented the effect of 17β-estradiol on IL-6. All three cell lines also expressed receptors for 1,25-dihydroxyvitamin-D3 [1,25(OH)2D3] (dissociation constant, ∼10-10 M), with a concentration of binding sites of 490 ± 20, 920 ± 20, and 1110 ± 70 sites per cell, respectively. 1,25(OH)2D3 treatment of the stromal cells caused a 2-fold increase in the concentration of ERs and a decrease in cell proliferation. These data establish that bone marrow-derived stromal cells express functional estrogen as well as vitamin D receptors, which serve to mediate actions of their respective ligands on the biosynthetic activity of these cells and presumably the effects of these two steroid hormones on osteoclastogenesis.

UR - http://www.scopus.com/inward/record.url?scp=0027170738&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027170738&partnerID=8YFLogxK

M3 - Article

C2 - 8393768

AN - SCOPUS:0027170738

VL - 133

SP - 553

EP - 562

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 2

ER -